On Nov. 13, the U.S. Food and Drug Administration (FDA) approved Abilify MyCite, a pill with a sensor that digitally tracks if patients have ingested their medication. Read more via Fda.gov.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder